<?xml version="1.0" encoding="UTF-8"?>
<p>The ACE2 receptor-related signaling pathways play an important role in several pathologies that are considered as comorbidities that increase the death rate of COVID-19 [
 <xref rid="B14-medicina-56-00386" ref-type="bibr">14</xref>]. Patients with hypertension and CVD have a high expression of this receptor and this might explain, in part, why symptoms are more pronounced in these patients and in related diseases including MS, diabetes, hypertension and hepatic diseases [
 <xref rid="B14-medicina-56-00386" ref-type="bibr">14</xref>].
</p>
